Robert Zerbe

Robert Zerbe

Net worth: 1 M $ as of 31/05/2026

75 year
Health Technology
Miscellaneous
Consumer Services

Profile

Dr. Robert L.
Zerbe
, MD, is an Independent Director at Cirius Therapeutics, Inc. and a Chairman at Vericel Corp.
He is on the Board of Directors at Cirius Therapeutics, Inc. and Indiana University Foundation, Inc. Dr. Zerbe was previously employed as an Independent Director by Optimer Pharmaceuticals LLC, a President, Chief Executive Officer & Director by QuatRx Pharmaceuticals Co., a SVP-Worldwide Clinical Research & Development by Parke-Davis &Co. (United States), a Senior VP-Global Research & Development by Pfizer Inc., a SVP-Worldwide, Clinical Research & Development by Warner-Lambert Co., a VP-Clinical Investigation & Regulatory Affairs by Eli Lilly & Co., a Managing Director by Lilly Research Center Ltd., and a President & Chief Executive Officer by Hormos Medical Oy.
He also served on the board at Metabolic Solutions Development Co. LLC, Anesiva, Inc., A.P.
Pharma, Inc., CymaBay Therapeutics, Inc., Edgemont Pharmaceuticals LLC and Maxim Pharmaceuticals, Inc. He received his doctorate degree from The Indiana University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
29/04/2026 32,995 ( 0.06% ) 1 M $ 31/05/2026

Robert Zerbe active positions

CompaniesPositionStart
VERICEL CORPORATION Chairman 05/10/2012
Director/Board Member -
Director/Board Member 01/05/2016

Former positions of Robert Zerbe

CompaniesPositionEnd
Founder 01/07/2016
Director/Board Member 24/10/2013
HERON THERAPEUTICS, INC. Director/Board Member 18/04/2011
Director/Board Member 15/12/2008
Director/Board Member 06/01/2006
See the detail of Robert Zerbe's experience

Training of Robert Zerbe

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology